Loop Gain in Obstructive Sleep Apnea: From Physiological Endotype to Clinical Translation

To define how loop gain can move from a physiological endotype to a clinically actionable metric in obstructive sleep apnea.

This clinical translational narrative review identified relevant literature from PubMed, Web of Science, Embase, and reference/citation searching, focusing on adult obstructive sleep apnea studies related to loop gain physiology, assessment methods, treatment stratification, and clinical implementation.

Loop gain helps explain why patients with similar apnea-hypopnea index values may show different disease expression and treatment responses. Research-grade perturbation methods remain the physiological reference standard, whereas raw-polysomnography (PSG) modeling currently represents the most practical route for clinical deployment. Simplified screening tools and emerging automated approaches based on polygraphy, photoplethysmography, or respiratory inductance plethysmography may expand access, provided their outputs are interpreted within method-specific contexts. Clinically, elevated loop gain may inform pre-treatment restratification before surgery or oral appliance therapy, selection of oxygen or ventilatory-control-targeted pharmacotherapy, and interpretation of residual instability during continuous positive airway pressure.

Loop gain is most useful as a selective decision-support metric rather than as an isolated physiological number. Staged implementation, method-specific reporting, and outcome-oriented studies are needed to determine when LG-guided stratification improves clinical decisions in obstructive sleep apnea.